Handbook ESRA
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Nerve Block of Lateral Femoral Cutaneous Nerve of the Thigh
18VTLLAA 1 Nerve block of lateral femoral cutaneous nerve of the thigh. Dr. Robert M Raw (MD) . MBChB, MFGP, MPraxMed, DA, FCA. Professor of Anesthesia retired Editor of Regional-Anesthesia.Com INDEX. 1. Introduction 2. Anatomy 3. Choice of local anesthetic 4. General indications 5. Complications and side effects 6. Conclusion ------------------------------------------------------------------------------------ 1. INTRODUCTION The lateral femoral cutaneous nerve of the thigh (LFCN) is the single human nerve most subject to anatomic variations. Figure #1shows the dermatome of LFCN. The nerve is small and mostly invisible under ultrasound scanning. For nerve block success, drug must be injected into four fascial compartments, each of which a variant nerve type may pass through in different individuals. 2. ANATOMY The lateral femoral cutaneous nerve is a sensory nerve supplying the skin on the lateral aspect of the thigh. That sensory area nearly reaches the thigh posterior midline and the thigh anterior midline. Its superior limit passes over the greater trochanter and its inferior limit nearly reaches the height of the patella. The typical LCNT, in 60% of patients, is a branch of the lumbar plexus deriving from the dorsal divisions of nerve roots L2 and L3. The LFCN forms within the psoas muscle, and exits the pelvis medial to the anterior superior iliac spine (ASIS) and under the inguinal ligament. It then passes over the sartorius muscle, under fascia lata, before branching into its final Figure 1. Classic dermatomal distribution of the divisions. In forty percent of patients the LFCN lateral femoral cutaneous nerve (LFCN), derived has completely different anatomy, but from Sobotta. fortunately the nerve always passes in proximity to the proximal sartorius muscle. -
Pharmacy Phacts in This Issue Pharmd Candidates Discuss Oral Health and Preventing Eye Strain at Work
Pharmacy Phacts In this issue PharmD candidates discuss Oral Health and Preventing Eye Strain At Work Oral Health Landon Forrest Stewart, PharmD Candidate 2021 Why is Oral Health important? Oral health is an important part of our overall health. Oral health issues can cause oral pain, increased costs in healthcare, and less productivity. Recent developments in oral hygiene have led to improved outcomes for patients. Many oral health issues are still prevalent today, but the good news is that many are preventable with daily healthy habits. Healthy habits are required to maintain good oral health and many oral health issues are still prevalent today. One of the most common oral health problems is decay in the tooth also known as a cavity. The outer layer of the tooth is a tough mineral layer called the enamel. Bacteria group together on teeth to form plaques that can erode the enamel and the deeper layers of your teeth, causing cavities. Cavities are present and untreated in up to 26% up American adults. (1) If left untreated, they can lead to pain in the tooth and more severe infections known as an abscess. Another common oral health problem is gum disease. When bacteria group together on the teeth, it causes the immune system to respond and causes inflammation in the mouth. The initial inflammation is called gingivitis and makes your gums swell and bleed more easily. Untreated gingivitis can progress to a more severe gum disease called periodontitis. Periodontitis can damage the structure that holds your teeth in place and is a common cause of tooth loss. -
Study Protocol
RESEARCH PROTOCOL Project Title A multicenter, single blind, randomized controlled trial of virucidal effect of Polyvinylpyrrolidone-Iodine on SARS-CoV-2 as well as safety of its application on nasopharynx & oropharynx of COVID-19 positive patients BMRC Reg. No: 38624012021 Page-1/17 Project Title A multicenter, single blind, randomized controlled trial of virucidal effect of Polyvinylpyrrolidone- Iodine on SARS-CoV-2 as well as safety of its application on nasopharynx & oropharynx of COVID- 19 positive patients. Summary Povidone Iodine (Iodine with water soluble polymer Polyvinylpyrolidone) or PVP-I is a proven and time trusted antiseptic agent having best possible (99.99%) virucidal effect in it‟s only 0.23% concentration, against all viruses including SARS-Co, MERS-CoV; even in SARS-COV-2 due to it‟s nonspecific mode of action for virus killing and having no resistance [1,2]. Corona virus is transmitted by/via respiratory droplets or aerosol, produced from sneezing or coughing of infected persons to healthy individual through mouth and nose mainly [5, 6]. The routes of entry of coronavirus in human body are mouth, nose and eye. PVP-I products for gargling the throat and spraying or washing the nose may have a preventive effect on COVID-19 and if it is proved in this study following human trial, this will be a landmark research in COVID-19 pandemic. In line of this, PVP-I containing oro-nasal spray, proposed Bangasafe, which should be regarded as PONS (Povidone Iodine oro-nasal spray) in this protocol, has been developed and proposed to use against corona virus disease. -
Viscotears Liquid Gel Later Than Four Weeks After First Opening
Viscotears® Liquid Gel carbomer (polyacrylic acid) Patient Information Leaflet This product will be called Viscotears in this leaflet. Please read this leaflet carefully before you start to use Viscotears. It contains important information. Keep the leaflet in a safe place because you may want to read it again. Do not share these eye drops with anyone else just in case you have an eye infection which you could pass on. If you have any other questions, or if there is something you don’t understand, please ask your pharmacist. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. In this leaflet: 1. What Viscotears is and what it’s used for 2. Things to consider before you start to use Viscotears 3. How to use Viscotears 4. Possible side effects 5. How to store Viscotears 6. Further information 1. What Viscotears is and what it’s used for Viscotears contains the active ingredient, carbomer (polyacrylic acid). Viscotears is used to make your eyes more comfortable when they feel dry. It is one of a group of eye drops called ‘artificial tears’. 2. Things to consider before you start to use Viscotears DO NOT use Viscotears if: If you are allergic to carbomer or any of the other ingredients of this medicine (listed in section 6). Take special care: In children and adolescents aged to 18 years, the safety and efficacy of Viscotears at the posology recommended in adults has been established by clinical experience, but no clinical trial data are available. -
Preparatory: 1 Venous Access and Medication Administration: 4
Preparatory: 1 Venous Access and Medication Administration: 4 W4444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444444 UNIT TERMINAL OBJECTIVE 1-4 At the completion of this unit, the EMT-Critical Care Technician student will be able to safely and precisely access the venous circulation and administer medications. COGNITIVE OBJECTIVES At the completion of this unit, the EMT-Critical Care Technician student will be able to: 1-4.1 Review the specific anatomy and physiology pertinent to medication administration. (C-1) 1-4.2 Review mathematical principles. (C-1) 1-4.3 Review mathematical equivalents. (C-1) 1-4.4 Differentiate temperature readings between the Centigrade and Fahrenheit scales. (C-3) 1-4.5 Discuss formulas as a basis for performing drug calculations. (C-1) 1-4.6 Calculate oral and parenteral drug dosages for all emergency medications administered to adults, infants and children. (C-2) 1-4.7 Calculate intravenous infusion rates for adults, infants, and children. (C-2) 1-4.8 Discuss legal aspects affecting medication administration. (C-1) 1-4.9 Discuss the "six rights" of drug administration and correlate these with the principles of medication administration. (C-1) 1-4.10 Discuss medical asepsis and the differences between clean and sterile techniques. (C-1) 1-4.11 Describe use of antiseptics and disinfectants. (C-1) 1-4.12 Describe the use of universal precautions and body substance isolation (BSI) procedures when administering a medication. (C-1) 1-4.13 Describe the indications, equipment needed, techniques utilized, precautions, and general principles of peripheral venous cannulation (Including saline locks). (C-1) 1-4.14 Describe the indications, equipment needed, techniques utilized, precautions, and general principles of intraosseous needle placement and infusion. -
Formulary Drug List
AMLODIPINE ORAL SUSPENSION Products Affected Step 2: • KATERZIA 1 MG/ML ORAL SUSPENSION Details Criteria PRIOR CLAIM FOR GENERIC AMLODIPINE TABLETS WITHIN THE PAST 120 DAYS. 1 ANTIBACTERIALS (EENT) Products Affected Step 2: • BESIVANCE 0.6 % EYE DROPS,SUSPENSION Details Criteria PRIOR CLAIM FOR FORMULARY VERSION OF CIPROFLOXACIN OPHTHALMIC OR OFLOXACIN OPHTHALMIC DROPS WITHIN THE LAST 120 DAYS. 2 ANTIDEPRESSANTS Products Affected Step 2: • FETZIMA 120 MG CAPSULE,EXTENDED RELEASE CAPSULE,EXTENDED RELEASE • FETZIMA 40 MG • FETZIMA 20 MG (2)-40 MG (26) CAPSULE,EXTENDED RELEASE CAPSULE,EXTENDED RELEASE,24 • FETZIMA 80 MG HR,DOSE PACK CAPSULE,EXTENDED RELEASE • FETZIMA 20 MG Details Criteria PRIOR CLAIM FOR TRINTELLIX AND VIIBRYD WITHIN THE PAST 365 DAYS. 3 ANTIPSYCHOTIC AGENTS Products Affected Step 2: • aripiprazole 10 mg disintegrating tablet • FANAPT 4 MG TABLET • aripiprazole 15 mg disintegrating tablet • FANAPT 6 MG TABLET • asenapine 10 mg sublingual tablet • FANAPT 8 MG TABLET • asenapine 2.5 mg sublingual tablet • SECUADO 3.8 MG/24 HOUR • asenapine 5 mg sublingual tablet TRANSDERMAL 24 HOUR PATCH • CAPLYTA 42 MG CAPSULE • SECUADO 5.7 MG/24 HOUR • clozapine 100 mg disintegrating tablet TRANSDERMAL 24 HOUR PATCH • clozapine 12.5 mg disintegrating tablet • SECUADO 7.6 MG/24 HOUR • clozapine 150 mg disintegrating tablet TRANSDERMAL 24 HOUR PATCH • clozapine 200 mg disintegrating tablet • VERSACLOZ 50 MG/ML ORAL • clozapine 25 mg disintegrating tablet SUSPENSION • FANAPT 1 MG TABLET • VRAYLAR 1.5 MG (1)-3 MG (6) • FANAPT 10 MG TABLET CAPSULES -
The Development of an Intramuscular Injection Simulation for Nursing Students
Open Access Technical Report DOI: 10.7759/cureus.12366 The Development of an Intramuscular Injection Simulation for Nursing Students Julia Micallef 1 , Artur Arutiunian 1 , Adam Dubrowski 1 1. Health Sciences, Ontario Tech University, Oshawa, CAN Corresponding author: Adam Dubrowski, [email protected] Abstract Intramuscular (IM) injections are preferred over subcutaneous injections for administering medicine such as epinephrine and vaccines as the muscle tissue contains an increased vascular supply that provides ideal absorption of the drug being administered. However, administering an IM injection requires clinical judgment when choosing the injection site, understanding the relevant anatomy and physiology as well as the principles and techniques for administering an IM injection. Therefore, it is essential to learn and perform IM injections using injection simulators to practice the skill before administering to a real patient. Current IM injection simulators either favor realism at the expense of standardization or are expensive but do not provide a realistic experience. Therefore, it is imperative to develop an inexpensive but realistic intramuscular injection simulator that can be used to train nursing students so that they can be prepared for when they enter the clinical setting. This technical report aims to provide an overview of the development of an inexpensive and realistic deltoid simulator geared to teach nursing students the skill of IM injections. After development, the IM simulators were tested and validated by practicing nurses. An 18-item survey was administered to the nurses, and results indicated positive feedback about the realism of the simulator, in comparison to previous models used, such as the Wallcur® PRACTI-Injecta Pads (Wallcur LLC, San Diego, CA). -
The Digestive System
69 chapter four THE DIGESTIVE SYSTEM THE DIGESTIVE SYSTEM The digestive system is structurally divided into two main parts: a long, winding tube that carries food through its length, and a series of supportive organs outside of the tube. The long tube is called the gastrointestinal (GI) tract. The GI tract extends from the mouth to the anus, and consists of the mouth, or oral cavity, the pharynx, the esophagus, the stomach, the small intestine, and the large intes- tine. It is here that the functions of mechanical digestion, chemical digestion, absorption of nutrients and water, and release of solid waste material take place. The supportive organs that lie outside the GI tract are known as accessory organs, and include the teeth, salivary glands, liver, gallbladder, and pancreas. Because most organs of the digestive system lie within body cavities, you will perform a dissection procedure that exposes the cavities before you begin identifying individual organs. You will also observe the cavities and their associated membranes before proceeding with your study of the digestive system. EXPOSING THE BODY CAVITIES should feel like the wall of a stretched balloon. With your skinned cat on its dorsal side, examine the cutting lines shown in Figure 4.1 and plan 2. Extend the cut laterally in both direc- out your dissection. Note that the numbers tions, roughly 4 inches, still working with indicate the sequence of the cutting procedure. your scissors. Cut in a curved pattern as Palpate the long, bony sternum and the softer, shown in Figure 4.1, which follows the cartilaginous xiphoid process to find the ventral contour of the diaphragm. -
A Potential Alternative Orodispersible Formulation to Prednisolone Sodium Phosphate Orally Disintegrating Tablets
pharmaceutics Article A Potential Alternative Orodispersible Formulation to Prednisolone Sodium Phosphate Orally Disintegrating Tablets Essam A. Tawfik 1,2,* , Mariagiovanna Scarpa 2, Hend E. Abdelhakim 2 , Haitham A. Bukhary 2,3, Duncan Q. M. Craig 2 , Susan A. Barker 4 and Mine Orlu 2 1 National Center for Pharmaceutical Technology, Life Science and Environment Research Institute, King Abdulaziz City for Science and Technology, P.O. Box 6086, Riyadh 11442, Saudi Arabia 2 Department of Pharmaceutics, UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK; [email protected] (M.S.); [email protected] (H.E.A.); [email protected] (H.A.B.); [email protected] (D.Q.M.C.); [email protected] (M.O.) 3 Department of Pharmaceutics, College of Pharmacy, Umm Al-Qura University, Makkah 24381, Saudi Arabia 4 Medway School of Pharmacy, The Universities of Greenwich and Kent at Medway, Anson Building Central Avenue, Chatham, Kent ME4 4TB, UK; [email protected] * Correspondence: etawfi[email protected] Abstract: The orally disintegrating tablet (ODT) has shown vast potential as an alternative oral dosage form to conventional tablets wherein they can disintegrate rapidly (≤30 s) upon contact with saliva fluid and should have an acceptable mouthfeel as long as their weight doesn’t exceed 500 mg. However, owing to the bitterness of several active ingredients, there is a need to find a suitable alternative to ODTs that maintains their features and can be taste-masked more simply and inexpensively. Therefore, electrospun nanofibers and solvent-cast oral dispersible films (ODFs) are used in this study as potential OD formulations for prednisolone sodium phosphate (PSP) that is Citation: Tawfik, E.A.; Scarpa, M.; commercially available as ODTs. -
Pressure Ulcer Staging Guide
Pressure Ulcer Staging Guide Pressure Ulcer Staging Guide STAGE I STAGE IV Intact skin with non-blanchable Full thickness tissue loss with exposed redness of a localized area usually Reddened area bone, tendon, or muscle. Slough or eschar may be present on some parts Epidermis over a bony prominence. Darkly Epidermis pigmented skin may not have of the wound bed. Often includes undermining and tunneling. The depth visible blanching; its color may Dermis of a stage IV pressure ulcer varies by Dermis differ from the surrounding area. anatomical location. The bridge of the This area may be painful, firm, soft, nose, ear, occiput, and malleolus do not warmer, or cooler as compared to have subcutaneous tissue and these adjacent tissue. Stage I may be Adipose tissue ulcers can be shallow. Stage IV ulcers Adipose tissue difficult to detect in individuals with can extend into muscle and/or Muscle dark skin tones. May indicate "at supporting structures (e.g., fascia, Muscle risk" persons (a heralding sign of Bone tendon, or joint capsule) making risk). osteomyelitis possible. Exposed bone/ Bone tendon is visible or directly palpable. STAGE II DEEP TISSUE INJURY Partial thickness loss of dermis Blister Purple or maroon localized area of Reddened area presenting as a shallow open ulcer discolored intact skin or blood-filled Epidermis with a red pink wound bed, without Epidermis blister due to damage of underlying soft slough. May also present as an tissue from pressure and/or shear. The intact or open/ruptured serum-filled Dermis area may be preceded by tissue that is Dermis blister. -
Bio-Implant Reference Manual
Bio-Implant Reference Manual International Use Only Bio-Implant Reference Manual Saving Lives, Restoring Health is our business. Nowhere is the reality of death more evident than in the decision-making process surrounding tissue and organ donation. It’s a course of action that involves everything from the simple to the complex, from the sadly certain to the certainly optimistic. LifeNet Health takes this tragedy and turns it into hope. Our full line of allograft bio-implants maximizes the precious gift of donated tissue and provides surgeons with the tools they need to improve the lives of patients. By making the finest quality allograft bio-implants easily accessible, we continue to provide exemplary service to clinicians and hospitals. Every year, LifeNet Health distributes over 400,000 bio-implants to meet the urgent needs of hospitals and patients around the world. Our record of safety is unmatched. And our philosophy is simple: When partnering with a bio-implant supplier, your decision should not be based solely on fee, but rather on the overall value you and your patients expect and deserve. At LifeNet Health, we deliver that value by excelling in these critical areas – safety, quality, innovation, service, clinical effectiveness, supply chain reliability and and experience. With LifeNet Health as your primary bio-implant supplier, you are investing in the best possible value to ensure the well-being of your patients and the reputation of your hospital. This is the value of working with LifeNet Health. 2 757-464-4761 x 2000 (OUS) • 888-847-7831 (US & Canada) • ©2014 LifeNet Health, Virginia Beach, VA. -
Avoid Empiric Treatment for Vulvar Skin Disorders
December 1, 2008 • www.familypracticenews.com Women’s Health 27 Avoid Empiric Treatment for Vulvar Skin Disorders BY NANCY WALSH vulva and anus. Hypopigmentation also is characteristic, ment once daily after soaking. “I believe the Temovate New York Bureau with scarring and architectural changes including phimo- brand is much better than the generic, probably because sis of the clitoris, resorption of the labia minora, and nar- of the vehicle,” he said. The corticosteroid should be con- L AKE B UENA V ISTA, FLA. — Empiric treatment rowing of the introitus causing recurrent tearing. It prob- tinued until active disease has resolved, not just for the 2 with corticosteroids should be avoided in patients who pre- ably is autoimmune, because patients have a high incidence weeks specified in the package insert. sent with vulvar symptoms such as burning, itching, pain, of other autoimmune diseases, especially thyroid disease. A second vulvar condition, lichen simplex chronicus, and dyspareunia, according to Dr. Andrew T. Goldstein. Lichen sclerosus can develop at any age, including is characterized by thick, lichenified skin of the labia ma- These patients should have a careful examination of the childhood, and is more common than generally appreci- jora and interlabial sulcus, accompanied by erosions, fis- vulva using a colposcope, and if a lesion is present, a 4- ated, with a prevalence of 1 in 70 women. But “you have suring, and tears in the skin that result from the patient’s mm punch biopsy is warranted. to look for it. The vulva is not just something to separate scratching in her sleep, said Dr.